http://www.druginjurylawyerblog.com/ Published by Pogust Braslow & Millrood en-us 2010-07-31T15:14:46-05:00 http://www.druginjurylawyerblog.com/2010/07/two_recent_studies_underscore_1.html The American Journal of Gastroenterology recently reported the results of its Proton Pump Inhibitor (PPI) clinical trial in “Dyseptic symptoms development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial, which confirmed an earlier study in Gastroenterology, entitled... Adverse Drug Update Derek T. Braslow 2010-07-31T15:14:46-05:00 http://www.druginjurylawyerblog.com/2010/07/zinc_cold_remedies_linked_to_l.html A new study published in the Archives of Otolaryngology – a journal of the American Medical Association – reports a link between over-the-counter zinc cold remedies and a loss of smell.... Adverse Drug Update Derek T. Braslow 2010-07-23T10:13:15-05:00 http://www.druginjurylawyerblog.com/2010/07/next_round_of_product_liabilit_1.html While Obama’s new Healthcare Reform laws have given approval to the next generation of lower cost, breakthrough drugs, called “biosimilar” drugs, these drugs will apparently not be required to undergo the same intensive clinical trial scrutiny as most other drugs.... Adverse Drug Update Derek T. Braslow 2010-07-22T15:15:20-05:00 http://www.druginjurylawyerblog.com/2010/07/finally_a_black_box_warning_fo_1.html On July 13, 2010, the Food and Drug Administration reported in a drug safety alert, that it is requiring Sanofi-Aventis to place a black box warning on its rheumatoid arthritis drug, Arava. Since Arava warnings were strengthened more than seven... Adverse Drug Update Derek T. Braslow 2010-07-16T16:44:08-05:00 http://www.druginjurylawyerblog.com/2010/07/benefits_of_adhd_drug_overstat_1.html Last week, as reported by the Associated Press, the FDA forced Shire, PLC to retract certain promotional materials after it scrutinized the claims made by the company regarding the benefits and risks of its drug Intuniv.... Adverse Drug Update Derek T. Braslow 2010-07-14T10:01:35-05:00 http://www.druginjurylawyerblog.com/2010/07/rapamune_offlabel_marketing_al_1.html In February 2010, federal prosecutors opened an investigation into promotional efforts by Wyeth – which is now under the umbrella of Pfizer, following their merge in late 2009 – relating to its transplant drug, Rapamune (sirolimus). Rapamune is a “immunosuppressive... Derek T. Braslow 2010-07-06T11:24:21-05:00 http://www.druginjurylawyerblog.com/2010/07/antidepressants_now_linked_to.html Add blindness to the growing list of side effects caused by antidepressants like Paxil, Celexa, Lexapro, Effexor and Zoloft. It is well-known that these drugs have been linked to suicide and cardiac birth defects, among others, but now, a June... Adverse Drug Update Derek T. Braslow 2010-07-02T13:42:44-05:00 http://www.druginjurylawyerblog.com/2010/07/testosterone_gel_linked_to_hea.html A June 30, 2010 article published in the New England Journal of Medicine and recently reported in Business Week, and Reuters has concluded that a new testosterone gel appears to raise the risk of heart-related problems in older men with... Adverse Drug Update Derek T. Braslow 2010-07-02T13:14:30-05:00 http://www.druginjurylawyerblog.com/2010/07/jj_and_mcneil_recall_update.html Add five more lots of over-the-counter medicines – four of Benadryl and one of Extra Strength Tylenol – to the growing number of products recalled by Johnson & Johnson’s McNeil Consumer Healthcare division this year.... Derek T. Braslow 2010-07-01T10:17:29-05:00 http://www.druginjurylawyerblog.com/2010/07/veterans_affairs_hospital_infe_1.html Earlier this week, the John Cochran VA Medical Center in St. Louis, Missouri began sending letters to armed forces veterans to advise them that they may have been exposed to blood borne pathogens while receiving dental care at the facility.... Derek T. Braslow 2010-07-01T10:07:23-05:00